Product Comparison


  Merck 00006404720 Merck 00006404741 Glaxo Smith Kline 58160074021 Glaxo Smith Kline 58160085452
McKesson # 1030987 544446 1223555 775513
Description RotaTeq® Rotavirus Vaccine Indicated for People 6 to 32 Weeks of Age Solution Single-Dose Tube 2 mL RotaTeq® Rotavirus Vaccine Indicated for People 6 to 32 Weeks of Age Solution Single-Dose Tube 2 mL Rotarix® Rotavirus Vaccine Indicated for People 6 to 24 Weeks of Age 10E6 / mL Solution Prefilled Oral Applicator 1.5 mL Rotarix® Rotavirus Vaccine Indicated for People 6 to 24 Weeks of Age 10E6 / mL Solution Single-Dose Kit 1 mL
Manufacturer # 00006404720000064047415816007402158160085452
Brand RotaTeq®RotaTeq®Rotarix®Rotarix®
Manufacturer MerckMerckGlaxo Smith KlineGlaxo Smith Kline
Invoice ROTATEQ VAC, SUSP 2ML LIVE PENTAV (25/BX)ROTATEQ VAC, SUSP 2ML LIVE PENTAV (10/PK)ROTARIX, ORAL DOSING APPL 1.5ML (10/CT)ROTARIX VACCINE, ORAL SUSP 10E6/ML 1ML (10/PK)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Container Type Single-Dose TubeSingle-Dose TubePrefilled Oral ApplicatorSingle-Dose Kit
Country of Origin United StatesUnited StatesUnknownUnknown
Generic Drug Code 26500265002427627017
Generic Drug Name Rotavirus Vaccine, Live, Oral PentavalentRotavirus Vaccine, Live, Oral PentavalentRotavirus Vaccine, Live, OralRotavirus Vaccine, Live Attenuated, 89-12, Preservative Free
NDC Number 00006404720000064047415816007402158160085452
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Strength 10E6 / mL10E6 / mL
User Indicated for People 6 to 32 Weeks of AgeIndicated for People 6 to 32 Weeks of AgeIndicated for People 6 to 24 Weeks of AgeIndicated for People 6 to 24 Weeks of Age
Volume 2 mL2 mL1.5 mL1 mL
Application Rotavirus VaccineRotavirus VaccineRotavirus VaccineRotavirus Vaccine
Dosage Form SolutionSolutionSolutionSolution
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Type OralOralOralOral
UNSPSC Code 51201618512016185120161851201618
Features and Benefits
  • RotaTeq® is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by types G1, G2, G3, G4, and G9
  • RotaTeq is approved for use in infants 6 weeks to 32 weeks of age
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
  • The dosing tube is contained in a pouch
  • Package of 25 individually pouched single-dose tubes
  • The vaccination series consists of three ready-to-use liquid doses of RotaTeq* administered orally starting at 6 to 12 weeks of age, with the subsequent doses administered at 4 to 10 week intervals
  • 10 individually pouched single dose tubes
  • Each dose is supplied in a container consisting of a squeezable plastic dosing tube with a twist-off cap, allowing for direct oral administration
  • Administer first dose to infants beginning at 6 weeks of age
  • Administer second dose after an interval of at least 4 weeks and prior to 24 weeks of age
  • Vial of lyophilized vaccine to be reconstituted with accompanying liquid diluent in a prefilled oral applicator
  • Includes a prefilled oral applicator of liquid diluent with a plunger stopper
  • Includes a transfer adapter for reconstitution
  • Store lyophilized vaccine refrigerated between 2 and 8 degrees C (36 and 46 degrees F)
  • Diluent may be stored at controlled room temperature